246 related articles for article (PubMed ID: 22780212)
21. A critical role for the EphA3 receptor tyrosine kinase in heart development.
Stephen LJ; Fawkes AL; Verhoeve A; Lemke G; Brown A
Dev Biol; 2007 Feb; 302(1):66-79. PubMed ID: 17046737
[TBL] [Abstract][Full Text] [Related]
22. Expression and tyrosine phosphorylation of Eph receptors suggest multiple mechanisms in patterning of the visual system.
Connor RJ; Menzel P; Pasquale EB
Dev Biol; 1998 Jan; 193(1):21-35. PubMed ID: 9466885
[TBL] [Abstract][Full Text] [Related]
23. Targeted therapy in haematological malignancies.
Hamilton A; Gallipoli P; Nicholson E; Holyoake TL
J Pathol; 2010 Mar; 220(4):404-18. PubMed ID: 20041451
[TBL] [Abstract][Full Text] [Related]
24. The role of protein kinase C-alpha in hematologic malignancies.
Lahn M; Sundell K; Köhler G
Acta Haematol; 2006; 115(1-2):1-8. PubMed ID: 16424642
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of drug resistance in hematologic malignancies.
Dalton WS
Semin Hematol; 1997 Oct; 34(4 Suppl 5):3-8. PubMed ID: 9408955
[TBL] [Abstract][Full Text] [Related]
26. The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors.
Alvarez RH; Kantarjian HM; Cortes JE
Cancer; 2006 Oct; 107(8):1918-29. PubMed ID: 16986126
[TBL] [Abstract][Full Text] [Related]
27. EphA3 biology and cancer.
Janes PW; Slape CI; Farnsworth RH; Atapattu L; Scott AM; Vail ME
Growth Factors; 2014 Dec; 32(6):176-89. PubMed ID: 25391995
[TBL] [Abstract][Full Text] [Related]
28. Role of the ephrin and Eph receptor tyrosine kinase families in angiogenesis and development of the cardiovascular system.
Zhang J; Hughes S
J Pathol; 2006 Mar; 208(4):453-61. PubMed ID: 16470907
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
30. Ephs and ephrins: emerging therapeutic targets in neuropathology.
Attwood BK; Patel S; Pawlak R
Int J Biochem Cell Biol; 2012 Apr; 44(4):578-81. PubMed ID: 22265656
[TBL] [Abstract][Full Text] [Related]
31. [Oral molecular targeting agents in hematological malignancy].
Wakabayashi S; Ohashi K
Gan To Kagaku Ryoho; 2010 Jul; 37(7):1214-8. PubMed ID: 20647701
[TBL] [Abstract][Full Text] [Related]
32. Pyrrolo[3,2-b]quinoxaline derivatives as types I1/2 and II Eph tyrosine kinase inhibitors: structure-based design, synthesis, and in vivo validation.
Unzue A; Dong J; Lafleur K; Zhao H; Frugier E; Caflisch A; Nevado C
J Med Chem; 2014 Aug; 57(15):6834-44. PubMed ID: 25076195
[TBL] [Abstract][Full Text] [Related]
33. EphA/ephrin-A interactions during optic nerve regeneration: restoration of topography and regulation of ephrin-A2 expression.
Rodger J; Vitale PN; Tee LB; King CE; Bartlett CA; Fall A; Brennan C; O'Shea JE; Dunlop SA; Beazley LD
Mol Cell Neurosci; 2004 Jan; 25(1):56-68. PubMed ID: 14962740
[TBL] [Abstract][Full Text] [Related]
34. Investigational antibody-drug conjugates for hematological malignancies.
Polson AG; Ho WY; Ramakrishnan V
Expert Opin Investig Drugs; 2011 Jan; 20(1):75-85. PubMed ID: 21142808
[TBL] [Abstract][Full Text] [Related]
35. MUC1 in hematological malignancies.
Stroopinsky D; Kufe D; Avigan D
Leuk Lymphoma; 2016 Nov; 57(11):2489-98. PubMed ID: 27347699
[TBL] [Abstract][Full Text] [Related]
36. Ephs and ephrins during early stages of chick embryogenesis.
Baker RK; Antin PB
Dev Dyn; 2003 Sep; 228(1):128-42. PubMed ID: 12950087
[TBL] [Abstract][Full Text] [Related]
37. [Role of ephrins in regulation of tumour cell migration].
Wybieralska E; Łaczna E; Madeja Z
Postepy Biochem; 2009; 55(2):153-62. PubMed ID: 19824471
[TBL] [Abstract][Full Text] [Related]
38. miR-155 as a novel clinical target for hematological malignancies.
Witten L; Slack FJ
Carcinogenesis; 2020 Mar; 41(1):2-7. PubMed ID: 31711135
[TBL] [Abstract][Full Text] [Related]
39. Eph-ephrin bidirectional signaling in physiology and disease.
Pasquale EB
Cell; 2008 Apr; 133(1):38-52. PubMed ID: 18394988
[TBL] [Abstract][Full Text] [Related]
40. The emerging role of CXC chemokines and their receptors in cancer.
Vinader V; Afarinkia K
Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
